BRWA
AVNR

B. Riley Wealth Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

B. Riley Wealth Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-400
Closed -$7 – 2656
2014
Q4 		$7 Buy
+400
New +$5.63K ﹤0.01% 3060
2014
Q3 		– Sell
-9,000
Closed -$50.8K – 2432
2014
Q2 		$50.8K Sell
9,000
-7,500
-45% -$34.6K 0.01% 1027
2014
Q1 		$61K Buy
16,500
+2,900
+21% +$11.1K 0.02% 715
2013
Q4 		$46K Buy
13,600
+5,100
+60% +$21.1K 0.01% 661
2013
Q3 		$36K Buy
+8,500
New +$40.3K 0.01% 660

B. Riley Wealth Advisors's AVNR Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 400 shares — an estimated $7 sold.

B. Riley Wealth Advisors first reported a position in AVNR in Q3 2013 and held it in 5 quarters. The position peaked at $61K in Q1 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 400 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $7.
  • B. Riley Wealth Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 5 quarters.
  • B. Riley Wealth Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $61K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.